Understanding indocyanine green angiography in polypoidal choroidal vasculopathy: The group experience with digital fundus photography and confocal scanning laser ophthalmoscopy

Retina

Volumn 34, Issue 12, 2014, Pages 2397-2406

  Cheung, Chui Ming Gemmy ^a,b,c   Lai, Timothy Y Y ^d   Chen, Shih Jen ^e   Chong, Victor ^f   Lee, Won Ki ^g   Htoon, Hla ^a   Ng, Wei Yan ^a   Ogura, Yuichiro ^h   Wong, Tien Yin ^a,b,c  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f OXFORD EYE HOSPITAL   (United Kingdom)

^g The Catholic University of Korea   (South Korea)

^h NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Anti vascular endothelial growth factor; Photodynamic therapy; Retreatment; Treatment

Indexed keywords

INDOCYANINE GREEN; COLORING AGENT;

AGE RELATED MACULAR DEGENERATION; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE STUDY; CONFOCAL SCANNING LASER OPHTHALMOSCOPE; CONFOCAL SCANNING LASER OPHTHALMOSCOPY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; FUNDUS CAMERA; GOLD STANDARD; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; MEDICAL SPECIALIST; PIGMENT EPITHELIUM; POLYPOIDAL CHOROIDAL VASCULOPATHY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RETINA DETACHMENT; SCANNING LASER OPHTHALMOSCOPY; SENSITIVITY AND SPECIFICITY; AGED; AREA UNDER THE CURVE; CHOROIDAL NEOVASCULARIZATION; CONFOCAL MICROSCOPY; DIAGNOSTIC USE; FLUORESCENCE ANGIOGRAPHY; MACULAR DEGENERATION; OPHTHALMOSCOPY; PHOTOGRAPHY; POLYPS; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC;

AGED; AREA UNDER CURVE; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FUNDUS OCULI; HUMANS; INDOCYANINE GREEN; MACULAR DEGENERATION; MALE; MICROSCOPY, CONFOCAL; OPHTHALMOSCOPY; PHOTOGRAPHY; POLYPS; PROSPECTIVE STUDIES; ROC CURVE;

EID: 84916642029     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000255     Document Type: Article

References (32)

1. Yannuzzi LA, Ciardella A, Spaide RF, et al. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 1997;115:478-485.
2. Laude A, Cackett PD, Vithana EN, et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration: same or different disease? Prog Retin Eye Res 2010;29:19-29.
3. Yuzawa M, Mori R, Kawamura A. The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol 2005;89:602-607.
4. Gomi F, Tano Y. Polypoidal choroidal vasculopathy and treatments. Curr Opin Ophthalmol 2008;19:208-212.
5. Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003;121:1392-1396.
6. Uyama M, Wada M, Nagai Y, et al. Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 2002;133: 639-648.
7. Nakashizuka H, Mitsumata M, Okisaka S, et al. Clinicopathologic findings in polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2008;49:4729-4737.
8. Lafaut BA, Aisenbrey S, Van den Broecke C, et al. Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina 2000;20:650-654.
9. Lim TH, Laude A, Tan CS. Polypoidal choroidal vasculopathy: an angiographic discussion. Eye (Lond) 2010;24:483-490.
10. Stanga PE, Lim JI, Hamilton P. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995;15:100-110.
11. Cohen SY, Dubois L, Quentel G, Gaudric A. Is indocyanine green angiography still relevant? Retina 2011;31:209-221.
12. Kokame GT. Polypoidal choroidal vasculopathy - an important diagnosis to make with therapeutic implications. Retina 2012;32:1446-1448.
13. Koh AH, Chen LJ, Chen SJ, et al. Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment. Retina 2013;33:686-716.
14. Japanese Study Group of Polypoidal Choroidal Vasculopathy. Criteria for diagnosis of polypoidal choroidal vasculopathy. Nippon Ganka Gakkai Zasshi 2005;109:417-427.
15. Leal S, Silva R, Figueira J, et al. Photodynamic therapy with verteporfin in polypoidal choroidal vasculopathy: results after 3 years of follow-up. Retina 2010;30:1197-1205.
16. Silva RM, Figueira J, Cachulo ML, et al. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 2005;243:973-979.
17. Koh A, Lee WK, Chen LJ, et al. EVEREST STUDY: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy. Retina 2012;32:1453-1456
18. Yuzawa M, Mori R, Haruyama M. A study of laser photocoagulation for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2003;47:379-384.
19. Gomi F, Sawa M, Mitarai K, et al. Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2007;245:1421-1427.
20. Cheung CM, Wong TY. Anti-VEGF debate: limitation in Asia. New Eng J Med 2011;365:2237.
21. Stangos AN, Gandhi JS, Nair-Sahni J, et al. Polypoidal choroidal vasculopathy masquerading as neovascular age-related macular degeneration refractory to ranibizumab. Am J Ophthalmol 2010;150:666-673.
22. Cho M, Barbazetto IA, Freund KB. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy. Am J Ophthalmol 2009;148: 70-78.
23. Iida T, Kishi S, Hagimura N, Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 1999;19:508-512.
24. Sasahara M, Tsujikawa A, Musashi K, et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol 2006;142:601-607.
25. Kwok AK, Lai TY, Chan CW, et al. Polypoidal choroidal vasculopathy in Chinese patients. Br J Ophthalmol 2002;86: 892-897.
26. Akaza E, Yuzawa M, Mori R. Three-year follow-up results of photodynamic therapy for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2011;55:39-44.
27. Akaza E, Yuzawa M, Matsumoto Y, et al. Role of photodynamic therapy in polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2007;51:270-277.
28. Akaza E, Mori R, Yuzawa M. Long-term results of photodynamic therapy of polypoidal choroidal vasculopathy. Retina 2008;28:717-722.
29. Kang SW, Chung SE, Shin WJ, Lee JH. Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography. Br J Ophthalmol 2009;93:759-764.
30. Cackett P, Wong D, Yeo I. A classification system for polypoidal choroidal vasculopathy. Retina 2009;29:187-191.
31. Okubo A, Hirakawa M, Ito M, et al. Clinical features of early and late stage polypoidal choroidal vasculopathy characterized by lesion size and disease duration. Graefes Arch Clin Exp Ophthalmol 2008;246:491-499.
32. Maruko I, Iida T, Saito M, Nagayama D. Combined cases of polypoidal choroidal vasculopathy and typical age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2010;248:361-368.